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While the first observations on the anti-tubercular activity of hydrazine
derivatives of isonicotinic acid5'6 were made using the experimental infec-
tion of mice with Mycobacterium tuberculosis var. hominis, it has become
evident through the work of Bernstein, Lott, Steinberg, and Yale' and
Steenken and Wolinsky11 that the bovine type of M. tuberculosis was also
markedly sensitive to the new chemotherapeutic agents. The experiments
with this organism that are being reported here supplement the work of
Bernstein, et al.' inasmuch as the observation time was extended in an
attempt to determine the duration of the protective effect brought about by
the administration of the new compounds. Moreover, the lungs of the ani-
mals used in these experiments were examined and the bacteriological
effect of the treatment was evaluated by culture. The observations made in
this study are discussed in the present paper.
MATERIALS AND METHODS
The Ravenel strain of M. tuberculosis var. bovis, obtained through the courtesy of
Dr. P. C. Eisman on June 18, 1951, was used in all the experiments.
In vitro and in vivo experiments. The techniques for evaluating the compounds in
vitro' and in vivo' have been described before. In the latter experiments adult albino
mice of 18-20 grams' weight originating from our colony were used. In addition to the
experiments where animals infected intravenously were treated by medicated diet for
21 days and observed for an additional 21-day period, experiments were also carried
out in which treatment by medicated diet was administered for a 28-day period and
the animals then observed for an additional 72 days. Post-mortem examinations were
carried out both on the animals that survived the observation period and also on
those that succumbed during the experiments. Whenever possible, cultures of the lungs
were made on egg-potato-medium'0 and histological sections taken.
EXPERIMENTAL RESULTS
In vitro experiments. The Ravenel strain of M. tuberculosis exhibited a
sensitivity to Rimifon (isonicotinic acid hydrazide) and Marsilid (1-iso-
nicotinyl-2-isopropylhydrazine) identical to that observed with the H37Rv
strain,6 namely, 0.015 mcg./ml. and 1.5 mcg./ml. respectively.
* From the Chemotherapy Laboratory, Hoffmann-La Roche, Inc., Nutley, New
Jersey.
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In vivo experiments. As representative compounds to show the effect of
the hydrazine derivatives of isonicotinic acid, Rimifon* and its isopropyl
derivative Marsilid were selected. In some experiments, a third hydrazine
derivative, namely, 1-isonicotinyl-2-d-glucosyl-hydrazine was included. The
effect of this atoxic glucosyl derivative (LDcso for mice = greater than
2500 mg./kg. subcutaneously; 1750 mg./kg. by gavage) has been described
by Zieper and Lewis' who employed this substance in a tuberculous
monkey. Its activity in mice infected with the bovine strain of M. tubercu-
losis has also been studied in the experiments reported by Bernstein, et al.'
For reasons of comparison compounds of known anti-tubercular activity
such as streptomycin, nicotinamide,9 nicotinaldehyde thiosemicarbazone,"7
and isonicotinaldehyde thiosemicarbazone"8 were also included.
Protective experiments with a treatment period of 21 days and an
observation period of an additional 21 days. In this group of experiments
the intravenously infected mice were kept on a medicated diet for 21 days
and then observed for an additional 21 days during which time they
received a normal diet of Borden's Chunx. The hydrazine derivatives as
well as streptomycin were tested at two dosage levels. The study with the
two thiosemicarbazones was limited to the higher dose since previous
experience had shown that no lasting effect could be expected in this series
of compounds.! The results of the experiments are given in Table 1. This
table does not contain information about the survival time, because all
animals treated with the different drugs were still alive at the end of the
42-day observation period. The controls, on the other hand, had the usual
average survival time of 22.1 days.
The data in Table 1, however, indicate that evaluation on the basis of
survival time only, without post-mortem examination, does not give a true
picture of the type of activity encountered in investigations of the anti-
tubercular activity of new compounds. The column "average extent of
lesions" which is based on the gross examination of the lungs clearly shows
that at the end of the 21-day observation period following 21 days' treat-
ment, anti-tubercular agents such as Rimifon and Marsilid still exerted a
marked inhibition on the development of gross pulmonary lesions. This
effect was found to be dependent on the dose inasmuch as the lower dose of
25.0 mg./kg./day allowed the development of somewhat more extensive
pulmonary involvement. The other agents included in this series of experi-
ments appeared considerably less active, particularly streptomycin. The
lesions in the mice receiving streptomycin were as marked as those of
the controls.
* Rimifon, Marsilid, 1-isonicotinyl-2-d-glucosyl hydrazine, and isonicotinaldehyde
thiosemicarbazone were synthesized by Dr. H. H. Fox, while nicotinaldehyde thio-
semicarbazone was synthesized by Dr. T. S. Gardner and Mr. E. Wenis in the Roche
Chemical Research Laboratories.
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The thiosemicarbazones of nicotinaldehyde and isonicotinaldehyde ap-
peared also inferior to the hydrazine derivatives of isonicotinic acid which
is in agreement with earlier results.'
As a rule, the histological examination of the tissues reflected the gross
findings inasmuch as the exudative lesions which dominate the micro-
scopical appearance of the pulmonary tuberculosis of mice were considera-
TABLE 1
DEGREE OF PULMONARY INVOLVEMENT AND CULTURAL RESULTS OF MICE INFECTED
INTRAVENOUSLY WITH M. TUBERCULOSIS VAR. BOVIS AND TREATED WITH
RIMIFON, MARSILID, OR KNOWN ANTITUBERCULAR AGENTS
Infection: 0.5 ml. of a 10-1 dilution of a 7-10-day-old culture intravenously.
Treatment: Medicated diet 21 days. Normal diet 21 days.
Number negative
Average cultures
Dose Number extent number animals
Compound mg./kg./day of animals of lesions cultured
Rimifon 250.0 38 0.24a 28/28
Marsilid 250.0 18 0.22 15/18
Nicotinaldehyde 250.0 18 1.94 3/13
thiosemicarbazone
Isonicotinaldehyde 250.0 10 1.5 3/8
thiosemicarbazone
Streptomycin 150.0 20 2.75 9/20
Rimifon 25.0 36 0.75 28/33
Marsilid 25.0 20 1.1 13/17
Streptomycin 50.0 17 2.65 0/6
Controls ... 23 2.83 0/9
a 3.0 = 70-100% gross pulmonary involvement.
2.0 = 40-70% gross pulmonary involvement.
1.0 = 15-40% gross pulmonary involvement.
bly less marked in organs of animals treated with the hydrazine derivatives
of isonicotinic acid. Complete lobular consolidation and even more exten-
sive confluent lesions as observed in controls or unsuccessfully treated ani-
mals were absent in the protected mice, although very small scattered
infiltrations were occasionally seen even in the lungs which appeared
normal at gross examination.
Under these circumstances the results of the cultural examinations of the
lungs seem to be of particular interest. The figures in the last column of
Table 1 clearly demonstrate the fact that the hydrazine derivatives of iso-
nicotinic acid and only these agents were able to prevent in a substantial
number of animals the growth of M. tuberculosis in cultures taken 21 days
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after discontinuance of treatment. The only anti-tubercular agent even
approaching a similar effect is streptomycin if given in a high dose. It seems
appropriate, however, to point out that the absence of growth by direct
culturing of lung tissue may not represent a sufficiently sensitive method to
allow any claims as to sterilization of the lung tissue by chemotherapy with
the hydrazine derivatives of isonicotinic acid. As in our earlier observations
of a similar nature' we can only claim that sufficient damage has been done
to the organisms or their number so substantially reduced that recovery is
no longer possible by cultural means.
TABLE 2
DEGREE OF PULMONARY INVOLVEMENT AND SURVIVAL TIME OF MICE INFECTED
INTRAVENOUSLY WITH M. TUBERCULOSIS VAR. BOVIS AND TREATED WITH RIMIFON,
ITS GLUCOSYL DERIVATIVE, STREPTOMYCIN, OR NICOTINAMIDE
Infection: 0.5 ml. of a 10. dilution of a 7-10-day-old culture intravenously.
Treatment: Medicated diet 28 days. Normal diet 72 days.
Number Average Average
Dose Number animals pulmonary survival time:
Compound mg./kg./day ofanimals surviving involvementa days
Rimifon 250.0 15 12 2.0b 97.9 ± 5.0
Glucosyl 250.0 20 19 1.6 99.3 ± 0.15
Streptomycin 150.0 15 5 ... 72.4 ± 24.2
Nicotinamide 2500.0 17 0 ... 20.8 ± 4.6
Rimifon 25.0 20 20 1.9 100.0 ± 0.0
Glucosyl 25.0 19 2 3.4 53.5 ± 23.5
Streptomycin 50.0 18 0 ... 48.8 ± 16.6
Controls ...... 20 0 3.8 21.7 ± 3.8
a Based on histological examination.
b4.0 = 100% pulmonary involvement.
3.0 = 75% pulmonary involvement.
2.0 = 50% pulmonary involvement.
1.0 = 25% pulmonary involvement.
Protective experiments with a treatment period of 28 days and an
observation period of an additional 72 days. Since the experiments
described in the first section of this paper did not show a characteristic end-
point of survival time, two groups of experiments were carried out in which
the total observation time was extended to 100 days. The treatment period
in these experiments was extended to 28 days instead of 21 days which
leaves a lapse of 72 days between the termination of therapy and the final
evaluation of the degree of protection.
In one of these experiments the usual intravenous infective dose of 0.5
ml. of a 101 dilution of a 7- to 10-day-old culture as employed in the
earlier experiments was used. The results of these observations are given in
Table 2. The average survival time as given in this table has been calcu-
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lated, with the surviving animals being assigned a survival time figure of
100 days although they were actually sacrificed. The results of survival
time are, therefore, supplemented by the number of surviving animals. This
set of figures indicates that Rimifon if given in a high dose of 250
mg./kg./day as well as at the small dosage level of 25 mg./kg./day pro-
tected all or the majority of mice. It was interesting that the glucosyl
derivative of Rimifon appeared fully active and comparable to Rimifon at
250 mg./kg./day, but at 25 mg./kg./day its effect dropped markedly and
only 2 out of 19 animals survived the 100-day period. Streptomycin, even
TABLE 3
SURVIVAL TIME AND CULTURAL RESULTS OF MICE INFECTED INTRAVENOUSLY WITH
M. TUBERCULOSIS VAR. BOVIS AND TREATED WITH RIMIFON, ITS
GLUCOSYL DERIVATIVE, STREPTOMYCIN, OR NICOTINAMIDE
Infection: 0.5 ml. of a 7-10-day-old undiluted culture intravenously.
Treatment: Medicated diet 28 days. Normal diet 72 days.
Number negative
Number Average cultures
Dose Numnber animals survival time number animals
Compound mg./kg./day ofanimals surviving days cultured
Rimifon 250.0 19 15 99.7 ± 15.9 9/12
Glucosyl 250.0 17 11 79.8 ± 28.2 2/8
Streptomycin 150.0 17 1 73.3 ± 13.2 ....
Nicotinamide 2500.0 19 0 18.2 ± 4.5 ....
Rimifon 25.0 12 10 95.3 ± 11.5 ...
Glucosyl 25.0 20 0 46.3 ± 17.9 ....
Streptomycin 50.0 16 2 64.3 ± 16.8 ....
Controls ...... 20 0 17.2 ± 4.8 ....
at a high dosage level of 150 mg./kg./day, was inferior to the hydrazine
derivatives of isonicotinic acid. Nicotinamide failed to show any degree of
protection although it always has a demonstrable effect in the infection with
the human strain of M. tuberculosis."9 All surviving animals exhibited at
gross as well as at microscopic examination lesions whose extent was, how-
ever, markedly reduced in all animals receiving Rimifon. A reduction of
lesions was observed with the glucosyl derivative of Rimifon only at the
high dosage level. Demonstration of tubercle bacilli in the sections of the
lungs of these mice also showed that only a few scattered acid-fast organ-
isms could be observed, while the lesions of the controls and unsuccessfully
treated animals contained numerous bacilli in dense clusters.
In a second experiment presented in Table 3 a heavier infection was
given, namely, 0.5 ml. of an undiluted culture, 7 to 10 days old, intra-
venously. Almost identical results were obtained as in the experiments just
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described. The length of the average survival time as well as the number of
animals surviving the entire period of observation was again most marked
in case of Rimifon. Its glucosyl derivative appeared less active even at the
high dosage level of 250 mg./kg./day. At the lower dose level, not only was
the prolongation of life markedly reduced, but no final survivors were
observed. Streptomycin in both dosages exhibited its well-known delay of
death, but the number of final survivors was negligible. Nicotinamide,
despite a high dose of 2500 mg./kg./day, was without effect in that the
mice succumbed at about the same time as the controls.
Cultures, which were only taken from surviving animals, further empha-
size the point that results based on survival time alone do not necessarily
indicate the complete picture of anti-tubercular activity of closely related
compounds. In the case of Rimifon an appreciable number of negative cul-
tures were obtained from surviving animals, while with its glucosyl deriva-
tive growth of M. tuberculosis was observed in the majority of the cultures
taken from the lungs.
DISCUSSION
The data given in the experimental part of this paper confirm the value
of the method of the fatal infection of mice with the Ravenel strain of M.
tuberculosis var. bovis for the evaluation of the anti-tubercular activity of
chemotherapeutic agents. The results also confirm the work of Bernstein,
et al.2 with the hydrazine derivatives of isonicotinic acid. Principally, the
results obtained in these experiments with the Ravenel strain of M. tuber-
culosis var. bovis corroborate those described in earlier publications"' for
M. tuberculosis H37Rv. Rimifon and Marsilid as the representative com-
pounds of the hydrazine derivatives of isonicotinic acid not only considera-
bly extended the survival time of the treated animals, but also produced
almost the same reduction in the extent of lesions as described in experi-
ments with M. tuberculosis var. hominis. Furthermore, the marked
influence on the viability of M. tuberculosis var. hominis could also be
demonstrated with the bovine type of M. tuberculosis even 72 days after
discontinuation of treatment.
The entirety of these findings suggests that the determination of limited
survival time as recommended by some authorse3 does not always allow the
necessary differentiation between chemically related compounds of different
degrees of activity. The glucosyl derivative of Rimifon which appears under
certain conditions equivalent to the parent substance can be shown to be
inferior to Rimifon by the use of lower dosage ranges, by extended observa-
tion time, and by cultural means. In addition, the undoubtedly marked effect
of streptomycin on the survival time loses its significance if one considers
the number of final survivors at the end of the extended survival time and
the presence of specific lesions. At the present time only Rimifon and the
related Marsilid seem to satisfy the requirement for anti-tubercular drugs
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which produce lasting protection apparently by their direct effect on the
viability of the causative organisms.
SUMMARY
1. The effect of hydrazine derivatives of isonicotinic acid in experimental
infections with M. tuberculosis var. bovis as described by Steenken and
Wolinsky and by Bernstein, et al. was confirmed in the present experiments
in mice.
2. Additional evidence is presented to show that the new agents, e.g.
Rimifon and Marsilid, exerted the same type of activity on the bovine type
of strain as was earlier reported for infections with M. tuberculosis var.
hominis. The oral administration of the compounds resulted in considerably
prolonged survival time, absence or reduction of tuberculous lesions in the
lungs, and prevention of growth of tubercle bacilli in cultures taken from
the lungs.
3. The demonstration of these properties of the hydrazine derivatives of
isonicotinic acid establishes their superiority to known anti-tubercular
drugs and also allows the evaluation of the therapeutic potency of
chemically closely related products.
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